Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3) > Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3):297-301

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Rivista di Dermatologia e Malattie Sessualmente Trasmesse


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

ORIGINAL ARTICLE  


Giornale Italiano di Dermatologia e Venereologia 2017 June;152(3):297-301

DOI: 10.23736/S0392-0488.16.05301-3

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study

Delia COLOMBO 1 , Sergio CHIMENTI 2, Paolo A. GROSSI 3, Antonio MARCHESONI 4, Rosario FOTI 5, Piergiacomo CALZAVARA-PINTON 6, Emanuela ZAGNI 1, Alessandra ORI 7, Gilberto BELLIA 1, on behalf of the SYNERGY Study Group 

1 Novartis Farma Italia, Origgio, Varese, Italy; 2 Tor Vergata Policlinic, Rome, Italy; 3 Ospedale di Circolo e Fondazione Macchi, Varese, Italy; 4 Pini Orthopedic Institute, Milan, Italy; 5 Azienda Universitaria Ospedaliera Policlinico Vittorio Emanuele, Catania, Italy; 6 Azienda Ospedaliera Spedali Civili, Brescia, Italy; 7 MediData Srl, Modena, Italy


PDF  


BACKGROUND: The SYNERGY Study is an observational, multicenter Italian study, conducted in patients with diagnosis of psoriatic arthritis (PsA) treated from at least 3 months with cyclosporine and aimed at assessing patients’ seropositivity for viral infections and efficacy and safety of cyclosporine, administered as monotherapy or in combination with other systemic drugs in the routine clinical practice. The aim of this subanalysis of the SYNERGY study was to evaluate the effects of CsA as monotherapy only in PsA over 12 months of observation.
METHODS: Psoriasis was evaluated by Body Surface Area and the Psoriasis Area Severity Index (PASI). PsA was evaluated by number of swollen and tender joints, painful entheses and fingers with dactylitis, the Bath Ankylosing Spondylitis Activity Index (BASDAI) and by patients’ and physicians’ global assessment on a 10-point Visual Analogue Scale.
RESULTS: Cyclosporine in monotherapy was effective in reducing all the measured disease parameters. The major indexes of cutaneous and spinal involvement, PASI and BASDAI were significantly reduced over the study period, as were the number of swollen and tender peripheral joints, and enthesitis and dactylitis.
CONCLUSIONS: Cyclosporine in monotherapy confirmed its efficacy in cutaneous psoriasis and suggested to be effective also on PsA, reducing spinal and peripheral joints’ signs and symptoms.


KEY WORDS: Cyclosporine - Observational study - Psoriasis - Arthritis, psoriatic

inizio pagina

Publication History

Issue published online: April 13, 2017
Article first published online: Febraury 2, 2016
Manuscript accepted: Janaury 25, 2016
Manuscript received: December 20, 2015

Per citare questo articolo

Colombo D, Chimenti S, Grossi PA, Marchesoni A, Foti R, Calzavara-Pinton P, et al.; SYNERGY Study Group. Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study. G Ital Dermatol Venereol 2017;152:297-301. DOI: 10.23736/S0392-0488.16.05301-3

the SYNERGY Study Group

Dahiana CASANOVA (Parma, Italy), Vito GRISETA (Bari, Italy), Sergio CHIMENTI (Rome, Italy), Anna GARGIULO (Caserta, Italy), Aurora PARODI (Genoa, Italy), Fabio AYALA (Naples, Italy), Federico BARDAZZI (Bologna, Italy), Germana CAMPLONE (Rome, Italy), Rosario FOTI (Catania, Italy), Piergiacomo CALZAVARA-PINTON (Brescia, Italy), Stefano DONELLI (Piacenza, Italy), Nicola ASTE (Cagliari, Italy), Ciro LAURITI (Pescara, Italy), Giovanni CRUCIANI (Rome, Italy), Stefano CALVIERI (Rome, Italy), Antonia G. GALLUCCIO (Benevento, Italy), Carlo MESCHINI (Viterbo, Italy), Gino A. VENA (Bari, Italy), Gianfranco ALTOMARE (Milan, Italy), Pierluigi FRUGIUELE (Cosenza, Italy), Chiara GIANNITTI (Siena, Italy), Marcello GOVONI (Ferrara, Italy), Pier P. SAINAGHI (Novara, Italy), Giancarlo VALENTI (Catanzaro, Italy)

Corresponding author e-mail

delia.colombo@novartis.com